<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>5</VOL>
    <DATE>2018-04-01</DATE>
    <ORIGINALDATE>2018-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Astringent active ingredients.</TITLE>
    <GRANULENUM>Â§ 346.18</GRANULENUM>
    <HEADING>Section Â§ 346.18</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 21" SEQ="4">Food and Drugs</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER D" SEQ="2">DRUGS FOR HUMAN USE</PARENT>
      <PARENT HEADING="PART 346" SEQ="1">ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE</PARENT>
      <PARENT HEADING="Subpart B" SEQ="0">Active Ingredients</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 346.18</SECTNO>
    <SUBJECT>Astringent active ingredients.</SUBJECT>
    <P>The active ingredient of the product consists of any of the following when used within the concentration range established for each ingredient:</P>
    <P>(a) Calamine, within a concentration range of 5 to 25 percent by weight per dosage unit (based on the zinc oxide content of calamine).</P>
    <P>(b) Witch hazel, 10 to 50 percent.</P>
    <P>(c) Zinc oxide, within a concentration range of 5 to 25 percent by weight per dosage unit.</P>
    <CITA>[55 FR 31779, Aug. 3, 1990, as amended at 59 FR 28767, June 3, 1994]</CITA>
  </SECTION>
</CFRGRANULE>
